WCM Investment Management LLC Trims Stock Holdings in Addus HomeCare Corporation $ADUS

WCM Investment Management LLC trimmed its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 49.3% in the 1st quarter, Holdings Channel reports. The firm owned 159,754 shares of the company’s stock after selling 155,315 shares during the quarter. WCM Investment Management LLC’s holdings in Addus HomeCare were worth $15,078,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Royal Bank of Canada raised its holdings in shares of Addus HomeCare by 24.3% in the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after acquiring an additional 2,952 shares in the last quarter. Jane Street Group LLC increased its stake in Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after purchasing an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Addus HomeCare by 44.7% in the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after acquiring an additional 4,439 shares during the period. Institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of recent research reports. Barclays raised their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Finally, Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.50.

View Our Latest Research Report on ADUS

Insider Buying and Selling

In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. The trade was a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 788 shares of company stock worth $73,506. Insiders own 4.10% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $111.50 on Tuesday. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The stock has a 50 day moving average price of $97.76 and a 200 day moving average price of $101.05. The stock has a market cap of $2.08 billion, a PE ratio of 20.61, a P/E/G ratio of 1.57 and a beta of 0.88.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm earned $1.42 earnings per share. Equities research analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Articles

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.